Abstract
Growth hormone (GH) has been reported to be useful to treat heart failure. To elucidate whether GH has direct beneficial effects on the heart, we examined effects of GH on oxidative stress-induced apoptosis in cardiac myocytes. TUNEL staining and DNA ladder analysis revealed that hydrogen peroxide (H2O2)-induced apoptosis of cardiomyocytes was significantly suppressed by the pretreatment with GH. GH strongly activated extracellular signal-regulated kinases (ERKs) in cardiac myocytes and the cardioprotective effect of GH was abolished by inhibition of ERKs. Overexpression of dominant negative mutant Ras suppressed GH-stimulated ERK activation. Overexpression of Csk that inactivates Src family tyrosine kinases also inhibited ERK activation evoked by GH. A broad-spectrum inhibitor of protein tyrosine kinases (PTKs), genistein, strongly suppressed GH-induced ERK activation and the cardioprotective effect of GH against apoptotic cell death. GH induced tyrosine phosphorylation of EGF receptor and JAK2 in cardiac myocytes, and an EGF receptor inhibitor tyrphostin AG1478 and a JAK2 inhibitor tyrphostin B42 completely inhibited GH-induced ERK activation. Tyrphostin B42 also suppressed the phosphorylation of EGF receptor stimulated by GH. These findings suggest that GH has a direct protective effect on cardiac myocytes against apoptosis and that the effect of GH is attributed at least in part to the activation of ERKs through Ras and PTKs including JAK2, Src, and EGF receptor tyrosine kinase.
Similar content being viewed by others
References
Gonzalo JA, Mazuchelli R, Mellado M, Frade JM, Carrera AC, von Kobbe C, Merida I, Martinez AC: Enterotoxin septic shock protection and deficient T helper 2 cytokine production in growth hormone transgenic mice. J Immunol 157: 3298–3304, 1996
Clark R: Growth hormone and insulin-like growth factor 1: New endocrine therapies in cardiology. Trends Cardiovasc Med 7: 264–268, 1997
Acevedo M, Corbalan R, Godoy I, Jalil J, Campusano C, Klaassen J: Growth hormone deficiency in patients with chronic heart failure. Rev Med Child 125: 30–35, 1997
Mathews LS, Enberg B, Norstedt G: Regulation of rat growth hormone receptor gene expression. J Biol Chem 264: 9905–9910, 1989
Isgaard J, Nilsson A, Vikman K, Isaksson OG: Growth hormone regulates the level of insulin-like growth factor-1 mRNA in rat skeletal muscle. J Endocrinol 120: 107–112, 1989
Cittadini A, Grossman JD, Napoli R, Katz SE, Stromer H, Smith RJ, Clark R, Morgan JP, Doglas PS: Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. JACC 29: 1109–1116, 1997
Kirby CJ, Thatcher WW, Collier RJ, Simmen FA, Lucy MC: Effects of growth hormone and pregnancy on expression of growth hormone receptor, insulin-like growth factor-I, and insulin-like growth factor binding protein-2 and-3 genes in bovine uterus, ovary, and oviduct. Biol Reprod 55: 996–1002, 1996
Unneberg K, Balteskard L, Mjaaland M, Sager G, Revhaug A: Growth hormone increases and IGF-1 reduces the response to Escherichia coli infusion in injured pigs. Eur J Surg 163: 779–788, 1997
Seger R, Krebs EG: The MAPK signaling cascade. FASEB J 9: 726-735, 1995
Page C, Doubell AF: Mitogen-activated protein kinase (MAPK) in cardiac tissues. Mol Cell Biochem 157: 49–57, 1996
Anderson NG: Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes. Biochem J 284: 649–652, 1992
Winston LA, Bertics PJ: Growth hormone stimulates the tyrosyl phosphorylation of 42-and 45-kDa ERK-related proteins. J Biol Chem 267: 4747–4751, 1992
Postel-Vinay MC: Growth hormone-and prolactin-binding proteins: Soluble forms of receptor. Hormone Res 45: 178–181, 1996
Carter-Su C, King AP, Argetsinger LS, Smit LS, Vanderkuur J, Campbell GS: Signalling pathway of GH. Endocr J 43: 65–70, 1996
Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter-Su C: Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74: 237–244, 1993
Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, Honjo M, Takahashi M, Takahashi T, Hirai H, Tushima T, Akanuma Y, Fujita T, Komuro I, Yazaki Y, Kadowaki T: Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390: 91–96, 1997
Feuerstein G, Robert R, RuffoloJr, Yue TL: Apoptosis and congestive heart failure. Trends Cardiovasc Med 7: 249–255, 1997
Pulkki KJ: Cytokines and cardiomyocyte death. Ann Med 29: 339–343, 1997
Ruffolo RR Jr, Feuerstein GZ: Carvedilol: Preclinical profile and mechanisms of action in preventing the progression of congestive heart failure. Eur Heart J 19: B19–24, 1998
Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Yazaki Y: Oxidative stress activates extracellular signal-regulated kinase through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 100: 1813–1821, 1997
Zou Y, Komuro I, Yamazaki T, Aikawa R, Kudoh S, Shiolima I, Hiroi Y, Mizuno T, Yazaki Y: Protein kinase C, but not tyrosine kinase or Ras, plays a critical role in angiotensin II-induced protein kinases in cardiac myocytes. J Biol Chem 271: 33592–33597, 1996
Bader D, Masaki T, Fischman DA: Immunochemical analysis of myosine heavy chain during avian myogenesis in vivo and in vitro. J Cell Biol 95: 763–770, 1982
Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326–1331, 1995
Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 270: 27489–27494, 1995
Love DW, Whatmore AJ, Clayton PE, Silva CM: Growth hormone stimulation of the mitogen-activated protein kinase pathway is cell type specific. Endocrinology 139: 1965–1971, 1998
Kyriakis JM, App H, Zhang XF, Banerjee P, Brautigan DL, Rapp UR, Avruch J: Raf-1 activates MAP kinase-kinase. Nature 358: 417–421, 1992
Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553–14556, 1993
Marshall CJ: Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179–185, 1995
Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM: Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379: 645–648, 1996
Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A: Signal characteristics of G protein-transactivated EGF receptor. EMBO J 16: 7032-7044, 1997
Wolbring G, Hollenberg MD, Schnetkamp PP: Inhibition of GTP-utilizing enzymes by tyrphostins. J Biol Chem 269: 22470–22472, 1994
Levitzki A, Gazit A: Tyrosine kinase inhibition: An approach to drug development. Science 267: 1782–1788, 1995
Kovalenko M, Gazit A, Bohmer A, Rorsman C, Ronnstrand L, Heldin CH, Waltenberger J, Bohmer FD, Levitzki A: Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res 54: 6106–6114, 1994
Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJ, Sabbadini RA: Tumor necrosis factor á-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98: 2854–2865, 1996
Eisenhauer KM, Chun SY, Billing H, Hsueh AJ: Growth hormone suppression of apoptosis in preovulatory rat follicles and partial neutralization by insulin-like growth factor binding protein. Biol Reprod 53: 13–20, 1995
Williams GT, Smith CA: Molecular regulation of apoptosis: Genetic controls on cell death. Cell 74: 777–779, 1993
Wang Y, Huang S, Sah VP, Ross J Jr, Brown JH, Han J, Chien KR: Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 273: 2161–2168, 1998
Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, Das DK: Ischemic preconditioning triggers the activation of MAP kinase and MAPKAP kinase 2 in rat hearts. FEBS Lett 396: 233–237, 1996
Gardner AM, Johnson GL: Fibroblast growth factor-2 suppression of tumor necrosis factor α-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J Biol Chem 271: 14560-14566, 1996
Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown JH, Chien KR: Cardiotrophin (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. J Biol Chem 272: 5783–5791, 1997
Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischark H, Finkenzeller G, Marme D, Rapp UR: Protein kinase C α activates RAF 1 by direct phosphorylation. Nature 364: 249–252, 1993
Brewer LM, Brown NA: Distribution of p21 ras in postimplantation rat embryos. Anat Rec 234: 443–451, 1992
Satoh T, Nakafuku M, Kaziro Y: Function of Ras as a molecular switch in signal transduction. J Biol Chem 267: 24149–24152, 1992
Linseman DA, Benjamin CW, Jones DA: Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem 270: 12563–12568, 1995
Zou Y, Komuro I, Yamazaki, Kudoh S, Aikawa R, Zhu W, Shiojima I, Hiroi Y, Tobe K, Kadowaki T, Yazaki Y: Cell type-specific angiotensin II-evoked signal transduction pathways: Critical roles of Gβγ subunit, Src family, and Ras in cardiac fibroblasts. Circ Res 82: 328–336, 1998
Argetsinger LS, Carter-Su C: Mechanism of signaling by growth hormone receptor. Physiol Rev 76: 1089–1107, 1996
Campbell GS, Pang L, Miyasaka T, Saltiel AR, Carter Su C: Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts. J Biol Chem 267: 6074–6080, 1992
Xu BC, Wang X, James C, Kopchick JJ: Characterization of growth hormone-induced tyrosine-phosphorylated proteins in mouse cell that express GH receptors. Receptor 5: 105–116, 1995
Dikic I, Tokiwa G, Lev S, Courtneidge SR, Schlessinger J: A role for PyK2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383: 547–550, 1996
Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA: Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363: 45–51, 1993
Yao R, Cooper GM: Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267: 2003-2006, 1995
Senaldi G, Shaklee CL, Simon B, Rowan CG, Lacey DL, Hartung T: Keratinocyte growth factor protects murine hepatocytes from tumor necrosis factor-induced apoptosis in vivo and in vitro. Hepatology 27: 1584–1591, 1998
Luttrell LM, Della Rocca GJ, van Biesen T, Luttrell DK, Lefkowitz RJ: Gβ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor mediated Ras activation. J Biol Chem 272: 4637–4644, 1997
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gu, Y., Zou, Y., Aikawa, R. et al. Growth hormone signalling and apoptosis in neonatal rat cardiomyocytes. Mol Cell Biochem 223, 35–46 (2001). https://doi.org/10.1023/A:1017941625858
Issue Date:
DOI: https://doi.org/10.1023/A:1017941625858